Home > Animal Health & Nutrition > Veterinary Active Pharmaceutical Ingredients (API) Market > Table of Contents

Veterinary Active Pharmaceutical Ingredients (API) Market Size - By Type (Anti-infectives, Anti-parasitic, NSAIDs), Synthesis Type (HPAPI, Biological, Chemical Based), Contract Outsourcing (CDMO, CMO), Drug Type - Global Forecast, 2023-2032

  • Report ID: GMI5410
  • Published Date: Jul 2023
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definition

1.2    Base estimates & calculations

1.3    Forecast parameters

1.4    COVID-19 impact analysis at global level

1.5    Data validation

1.6    Data Sources

1.6.1    Primary

1.6.2    Secondary

1.6.2.1   Paid sources

1.6.2.2   Unpaid sources

Chapter 2   Executive Summary

2.1    Global veterinary active pharmaceutical ingredients market 360° synopsis, 2018 - 2032

2.1.1    Business trends

2.1.2    Regional trends

2.1.3    Type trends

2.1.4    Synthesis type trends

2.1.5    Route of administration trends

2.1.6    Service type trends

2.1.7    Animal type trends

Chapter 3   Veterinary Active Pharmaceutical Ingredients Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1   Increasing demand for pet insurance

3.2.1.2   Surging awareness of animal health, physical, and mental well-being

3.2.1.3   Increasing demand for animal products

3.2.1.4   Favorable government initiatives

3.2.1.5   Growing pet adoption

3.2.2    Industry pitfalls & challenges

3.2.2.1   Low out of pocket expenditure on veterinary care

3.2.2.2   High cost of veterinary medicines

3.3    Growth potential analysis

3.3.1    By type

3.3.2    By synthesis type

3.3.3    By route of administration

3.3.4    By service type

3.3.5    By animal type

3.4    COVID- 19 impact analysis

3.5    Technology landscape

3.6    Regulatory landscape

3.6.1    U.S.

3.6.2    Europe

3.6.3    Asia Pacific

3.7    Supply chain analysis

3.8    Key market trends

3.9    Pipeline analysis

3.10    Porter's analysis

3.11    PESTEL analysis

Chapter 4   Competitive Landscape, 2022

4.1    Introduction

4.2    Company matrix analysis, 2022

4.3    Company positioning matrix

4.4    Competitive analysis of major market players

4.5    Strategy dashboard, 2022

Chapter 5   Veterinary Active Pharmaceutical Ingredients Market Size and Forecast, By Type (USD Million)

5.1    Key trends, by type

5.2    Anti-infectives

5.3    Anti-parasitics

5.4    Vaccines

5.5    Hormones

5.6    Biologics

5.7    Anti-inflammatory

5.8    Other APIs

Chapter 6   Veterinary Active Pharmaceutical Ingredients Market Size and Forecast, By Synthesis Type (USD Million)

6.1    Key trends, by synthesis type

6.2    Chemical based API

6.3    Biological API

6.4    Highly potent API (HPAPI)

Chapter 7   Veterinary Active Pharmaceutical Ingredients Market Size and Forecast, By Route of Administration (USD Million)

7.1    Key trends, by route of administration

7.2    Oral

7.3    Injectable

7.4    Topical

7.5    Other routes

Chapter 8   Veterinary Active Pharmaceutical Ingredients Market Size and Forecast, By Service Type (USD Million)

8.1    Key trends, by service type

8.2    In-house

8.3    Contract outsourcing

8.3.1    Contract development

8.3.2    Contract manufacturing

Chapter 9   Veterinary Active Pharmaceutical Ingredients Market Size and Forecast, By Animal Type (USD Million)

9.1    Key trends, by animal type

9.2    Companion animals

9.3    Livestock animals

Chapter 10   Veterinary Active Pharmaceutical Ingredients Market Size and Forecast, By Region (USD Million)

10.1    Key trends, by region

10.2    North America

10.2.1    U.S.

10.2.2    Canada

10.3    Europe

10.3.1    Germany

10.3.2    UK

10.3.3    France

10.3.4    Spain

10.3.5    Italy

10.3.6    Rest of Europe

10.4    Asia Pacific

10.4.1    Japan

10.4.2    China

10.4.3    India

10.4.4    Australia

10.4.5    South Korea

10.4.6    Rest of Asia Pacific

10.5    Latin America

10.5.1    Brazil

10.5.2    Mexico

10.5.3    Argentina

10.5.4    Rest of Latin America

10.6    Middle East & Africa

10.6.1    South Africa

10.6.2    Saudi Arabia

10.6.3    UAE

10.6.4    Rest of Middle East & Africa

Chapter 11   Company Profiles

11.1    Alivira Animal Health Ltd.

11.2    SUANFARMA

11.3    Procyon Life Sciences

11.4    Jiangsu Lingyun Pharmaceutical Co., Ltd.

11.5    Ofichem Group

11.6    NGL Fine-Chem Ltd

11.7    Huvepharma

11.8    Excel Veterinary Healthcare

11.9    Menadiona

11.10    Indukern Group

11.11    Vetpharma (Insud Pharma)

11.12    Qilu Pharmaceutical (Inner Mongolia) Co., Ltd.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 257
  • Countries covered: 23
  • Pages: 236
 Download PDF